These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L; J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085 [TBL] [Abstract][Full Text] [Related]
29. An update on aspirin in the primary prevention of cardiovascular disease. Eidelman RS; Hebert PR; Weisman SM; Hennekens CH Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112 [TBL] [Abstract][Full Text] [Related]
30. A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study. Gómez-Isla T; Blesa R; Boada M; Clarimón J; Del Ser T; Domenech G; Ferro JM; Gómez-Ansón B; Manubens JM; Martínez-Lage JM; Muñoz D; Peña-Casanova J; Torres F; Alzheimer Dis Assoc Disord; 2008; 22(1):21-9. PubMed ID: 18317243 [TBL] [Abstract][Full Text] [Related]
31. Antithrombotic drugs for the secondary prevention of ischemic stroke. Nenci GG; Goracci S Ann Ital Med Int; 2000; 15(4):282-90. PubMed ID: 11202630 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. Falco A; Salvati F; Vitacolonna E; Avellone G; Pinto A; Di Febbo C; Ballone E; Di Nicola M; Ciabattoni G; Davì G Atherosclerosis; 2005 Dec; 183(2):329-35. PubMed ID: 16285996 [TBL] [Abstract][Full Text] [Related]
34. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease. Hennekens CH; Schneider WR Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910 [TBL] [Abstract][Full Text] [Related]
35. Action of 2-acetoxy-trifluoromethylbenzoic acid (Triflusal) on platelet function after repeated oral administration in man: a pharmacological clinical study. Messa GL; Franchi M; Auteri A; Di Perri T Int J Clin Pharmacol Res; 1993; 13(5):263-73. PubMed ID: 8200721 [TBL] [Abstract][Full Text] [Related]
36. Effects of triflusal and acetylsalicylic acid on microthrombi formation in experimental brain ischemia. Heye N; Campos A; Kannuki S; Cervós-Navarro J Exp Pathol; 1991; 41(1):31-6. PubMed ID: 2022253 [TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of atrial fibrillation patients in the NASPEAF study. Prospective evaluation of different antiplatelet treatments. Bover R; Pérez-Gómez F; Maluenda MP; Asenjo S; Pérez-Saldaña R; Igea A; Suárez M; Coleto D; Fernández C Rev Esp Cardiol; 2009 Sep; 62(9):992-1000. PubMed ID: 19712620 [TBL] [Abstract][Full Text] [Related]
38. [Use of aspirin in the primary prevention of vascular thrombi. A comparative study with other anti-aggregant drugs]. Escudero MC; Alvarez L; Rodríguez V; de Haro J; Millán I; Castillo-Olivares JL Rev Esp Cardiol; 1989 Oct; 42(8):536-40. PubMed ID: 2602610 [TBL] [Abstract][Full Text] [Related]
39. [Acetylsalicylic acid after myocardial infarct]. Sinzinger H; Kritz H Wien Klin Wochenschr; 1997; 109 Suppl 2():25-8. PubMed ID: 9340919 [TBL] [Abstract][Full Text] [Related]
40. Triflusal: a review of its use in cerebral infarction and myocardial infarction, and as thromboprophylaxis in atrial fibrillation. Murdoch D; Plosker GL Drugs; 2006; 66(5):671-92. PubMed ID: 16620146 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]